Brabourne Enterprises Ltd(merged)
- Market Cap ₹ Cr.
- Current Price ₹ 10.0
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 0.36 %
- ROE -8.36 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has a low return on equity of 8.98% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| 146 | 121 | 0 | |
| 120 | 99 | 29 | |
| Operating Profit | 25 | 22 | -29 |
| OPM % | 17% | 18% | |
| 27 | 4 | 2 | |
| Interest | 18 | 12 | 0 |
| Depreciation | 6 | 5 | 0 |
| Profit before tax | 28 | 10 | -27 |
| Tax % | 9% | 17% | 11% |
| 26 | 8 | -30 | |
| EPS in Rs | |||
| Dividend Payout % | 14% | 26% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -168% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| Last Year: | -8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| Equity Capital | 14 | 14 | 14 |
| Reserves | 51 | 57 | 48 |
| 97 | 85 | 1 | |
| 59 | 43 | 1 | |
| Total Liabilities | 222 | 200 | 65 |
| 30 | 26 | 1 | |
| CWIP | 0 | 12 | 0 |
| Investments | 95 | 90 | 53 |
| 98 | 72 | 11 | |
| Total Assets | 222 | 200 | 65 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| 44 | 15 | 0 | |
| 49 | -6 | 0 | |
| -66 | -28 | -3 | |
| Net Cash Flow | 27 | -19 | -2 |
| Free Cash Flow | 39 | 2 | 0 |
| CFO/OP | 193% | 70% | -1% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | |
|---|---|---|---|
| Debtor Days | 64 | 74 | |
| Inventory Days | 183 | 168 | |
| Days Payable | 297 | 269 | |
| Cash Conversion Cycle | -51 | -28 | |
| Working Capital Days | 20 | 52 | |
| ROCE % | 13% | 0% |
Documents
Announcements
No data available.
Annual reports
No data available.